Published in Arch Gesamte Virusforsch on January 01, 1974
Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J Virol (1985) 2.34
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol (1994) 2.21
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol (1992) 1.75
Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol (1996) 1.74
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA. J Virol (1993) 1.64
Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J Virol (1994) 1.64
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med (1981) 1.62
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
Subgenomic negative-strand RNA function during mouse hepatitis virus infection. J Virol (2000) 1.48
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J Virol (1993) 1.44
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol (2001) 1.41
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol (1999) 1.38
Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal. J Virol (1995) 1.36
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A (1995) 1.34
In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest (1987) 1.33
Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J Virol (1999) 1.28
The subcellular distribution of an RNA quality control protein, the Ro autoantigen, is regulated by noncoding Y RNA binding. Mol Biol Cell (2008) 1.26
Mouse hepatitis virus S RNA sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. J Virol (1991) 1.25
Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages. Infect Immun (1980) 1.23
RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells. J Virol (2000) 1.22
The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J Virol (1992) 1.22
Unusual heterogeneity of leader-mRNA fusion in a murine coronavirus: implications for the mechanism of RNA transcription and recombination. J Virol (1994) 1.21
Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: correlation with the amounts of subgenomic mRNA transcribed. J Virol (1995) 1.21
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol (1988) 1.19
Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol (2003) 1.19
Assembled coronavirus from complementation of two defective interfering RNAs. J Virol (1997) 1.18
The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Virol (1995) 1.17
Soluble receptor potentiates receptor-independent infection by murine coronavirus. J Virol (2002) 1.17
The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry. J Virol (2005) 1.15
Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J Virol (1997) 1.13
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J Virol (1995) 1.13
RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc Natl Acad Sci U S A (1987) 1.11
Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3' untranslated region, thereby altering RNA conformation. J Virol (1999) 1.10
Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. J Virol (2004) 1.10
Coronavirus mRNA transcription: UV light transcriptional mapping studies suggest an early requirement for a genomic-length template. J Virol (1992) 1.07
Induction of caspase-dependent apoptosis in cultured rat oligodendrocytes by murine coronavirus is mediated during cell entry and does not require virus replication. J Virol (2003) 1.04
Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04
RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments. J Virol (1992) 1.03
Importance of the positive-strand RNA secondary structure of a murine coronavirus defective interfering RNA internal replication signal in positive-strand RNA synthesis. J Virol (1998) 1.02
Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J Virol (2006) 1.01
Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J Virol (2004) 1.01
SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis. J Virol (2004) 0.97
Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release. J Virol (2005) 0.96
Role of polypyrimidine tract binding protein in the function of the hepatitis B virus posttranscriptional regulatory element. J Virol (2001) 0.96
Replication of mouse hepatitis viruses with high and low virulence in cultured hepatocytes. Infect Immun (1983) 0.95
Human carcinoembryonic antigen and biliary glycoprotein can serve as mouse hepatitis virus receptors. J Virol (1997) 0.95
Coronavirus transcription early in infection. J Virol (1998) 0.95
Expression of cellular oncogene Bcl-xL prevents coronavirus-induced cell death and converts acute infection to persistent infection in progenitor rat oligodendrocytes. J Virol (2005) 0.94
Murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread. J Virol (2010) 0.93
Correlation between growth potential of mouse hepatitis viruses in macrophages and their virulence for mice. Infect Immun (1981) 0.93
Two murine coronavirus genes suffice for viral RNA synthesis. J Virol (1995) 0.93
Role of the mitochondrial signaling pathway in murine coronavirus-induced oligodendrocyte apoptosis. J Virol (2006) 0.93
Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J Virol (1992) 0.90
Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J Virol (1998) 0.89
Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15. J Virol (2008) 0.89
The leader RNA of coronavirus mouse hepatitis virus contains an enhancer-like element for subgenomic mRNA transcription. J Virol (2000) 0.89
Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J Virol (1996) 0.87
Induction of transcription factor Egr-1 gene expression in astrocytoma cells by Murine coronavirus infection. Virology (2006) 0.85
Murine coronavirus-induced oligodendrocyte apoptosis is mediated through the activation of the Fas signaling pathway. Virology (2006) 0.83
A 5'-proximal RNA sequence of murine coronavirus as a potential initiation site for genomic-length mRNA transcription. J Virol (1996) 0.82
LCMV glycosylation modulates viral fitness and cell tropism. PLoS One (2013) 0.81
Regulation of proinflammatory cytokine expression in primary mouse astrocytes by coronavirus infection. J Virol (2009) 0.80
The spike protein of murine coronavirus regulates viral genome transport from the cell surface to the endoplasmic reticulum during infection. J Virol (2009) 0.80
Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity. J Virol (1996) 0.79
Spontaneous production of interleukin-2 and interleukin-3 by spleen cells from mice infected with mouse hepatitis virus type 4. J Virol (1988) 0.78
Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance. J Virol (2014) 0.77
Simultaneous detection of antibodies to mouse hepatitis virus recombinant structural proteins by a microsphere-based multiplex fluorescence immunoassay. Clin Vaccine Immunol (2011) 0.75
Fluorescent antibody localization of myosin in the cytoplasm, cleavage furrow, and mitotic spindle of human cells. J Cell Biol (1976) 6.94
Microtubules: evidence for 13 protofilaments. J Cell Biol (1973) 4.91
Microtubules and the endoplasmic reticulum are highly interdependent structures. J Cell Biol (1986) 4.59
A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J (1994) 3.88
Isolation of human rotavirus in cell cultures: brief report. Arch Virol (1981) 3.83
Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med (1999) 3.72
DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol (1999) 3.17
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol (2001) 2.97
Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells. Cell (1979) 2.84
Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol (1976) 2.82
Simultaneous localization of myosin and tubulin in human tissue culture cells by double antibody staining. J Cell Biol (1978) 2.59
Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin. J Cell Biol (1978) 2.54
Characterization and localization of myosin in the brush border of intestinal epithelial cells. J Cell Biol (1978) 2.47
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
High actin concentrations in brain dendritic spines and postsynaptic densities. Proc Natl Acad Sci U S A (1982) 2.31
Redistribution of myosin accompanying capping of surface Ig. J Exp Med (1977) 2.18
Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol (1999) 2.13
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology (2001) 2.02
Rho-kinase--mediated contraction of isolated stress fibers. J Cell Biol (2001) 1.92
Collagen modulates cell shape and cytoskeleton of embryonic corneal and fibroma fibroblasts: distribution of actin, alpha-actinin, and myosin. Dev Biol (1982) 1.86
Organization and function of stress fibers in cells in vitro and in situ. A review. Cell Muscle Motil (1984) 1.85
Alpha-actinin localization in the cleavage furrow during cytokinesis. J Cell Biol (1978) 1.84
Stress fiber organization regulated by MLCK and Rho-kinase in cultured human fibroblasts. Am J Physiol Cell Physiol (2001) 1.81
Organization of actin, myosin, and intermediate filaments in the brush border of intestinal epithelial cells. J Cell Biol (1982) 1.79
Ductal aneurysm of adult patients. Jpn J Thorac Cardiovasc Surg (2000) 1.78
Defective interfering particles of mouse hepatitis virus. Virology (1984) 1.76
Antigenic relationships between rotaviruses from different species as studied by neutralization and immunofluorescence. Arch Virol (1982) 1.72
Researches on Vaccine Virus in Vitro with Special References to its Affinity for Nerve Tissue. Am J Pathol (1925) 1.65
Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of "adenoma malignum". Gynecol Oncol (1999) 1.62
Persistent, tolerant or subacute infection in Borna disease virus-infected rats. J Gen Virol (1983) 1.62
Isolation and contraction of the stress fiber. Mol Biol Cell (1998) 1.61
Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol (1981) 1.58
Factors influencing the expression of stress fibers in vascular endothelial cells in situ. J Cell Biol (1983) 1.54
Amplification and detection of a single molecule of human immunodeficiency virus RNA. Virus Genes (1993) 1.53
Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res (1985) 1.53
Myelopathy hand. New clinical signs of cervical cord damage. J Bone Joint Surg Br (1987) 1.53
Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology (1992) 1.52
Substructural analysis of the microtubule and its polymorphic forms. Ann N Y Acad Sci (1975) 1.50
Effect of T-cell transfer on Pneumocystis carinii infection in nude mice. Jpn J Exp Med (1984) 1.50
Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol (1986) 1.47
Relation between colour vision loss and occupational styrene exposure level. Occup Environ Med (2002) 1.47
Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii. Infect Immun (1985) 1.45
Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. Oncogene (2006) 1.45
Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. J Gastroenterol (2000) 1.45
Use of the curved linear-array echo endoscope to identify gastrorenal shunts in patients with gastric fundal varices. Endoscopy (2004) 1.44
Mouse hepatitis virus (MHV-2). Plaque assay and propagation in mouse cell line DBT cells. Jpn J Microbiol (1976) 1.43
Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration. Intern Med (1997) 1.42
Coronaviridae. Intervirology (1983) 1.42
Population dynamics of phenol-degrading bacteria in activated sludge determined by gyrB-targeted quantitative PCR. Appl Environ Microbiol (1998) 1.42
Minor contribution of hepatocytes to collagen production in normal and early fibrotic rat livers. Hepatology (1991) 1.38
Midterm results after ventricular septation for double-inlet left ventricle in early infancy. Ann Thorac Surg (2001) 1.38
Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA. Blood (1995) 1.38
Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest (1993) 1.38
Immunological cross reactivity of Mason-Pfizer monkey virus with type C RNA viruses endogenous to primates. Nature (1976) 1.37
Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology (1998) 1.36
Effect of Web-based lifestyle modification on weight control: a meta-analysis. Int J Obes (Lond) (2011) 1.36
Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (1999) 1.35
Stress fibers in cells in situ: immunofluorescence visualization with antiactin, antimyosin, and anti-alpha-actinin. J Cell Biol (1982) 1.35
Molecular cloning of bovine actin-like protein, actin2. Biochem Biophys Res Commun (1992) 1.35
Antigenic determinants of the 70,000 molecular weight glycoprotein of woolly monkey type C RNA virus. J Immunol (1975) 1.35
Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Oncogene (2006) 1.33
A case of spontaneous regression of hepatocellular carcinoma with bone metastasis. Cancer (1985) 1.31
Experimental Pneumocystis carinii infection in nude rats. Jpn J Exp Med (1984) 1.31
Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens (2003) 1.31
Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol (1997) 1.30
Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proc Natl Acad Sci U S A (1977) 1.30
Thoracic myelopathy secondary to ossification of the spinal ligament. J Neurosurg (1987) 1.29
Distribution of alpha-actinin in single isolated smooth muscle cells. J Cell Biol (1983) 1.29
Chicken liver H-protein, a component of the glycine cleavage system. Amino acid sequence and identification of the N epsilon-lipoyllysine residue. J Biol Chem (1986) 1.27
Heterogeneity of myosin antigenic expression in vascular smooth muscle in vivo. Lab Invest (1984) 1.26
Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in mechanically stimulated vascular endothelial cells. Eur J Cell Biol (1997) 1.25
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Causes of neurologic deterioration following surgical treatment of cervical myelopathy. Spine (Phila Pa 1976) (1986) 1.24
Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn J Exp Med (1978) 1.24
Local structures in unfolded lysozyme and correlation with secondary structures in the native conformation: helix-forming or -breaking propensity of peptide segments. Biopolymers (1991) 1.24
Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages. Infect Immun (1980) 1.23
Differential expression of helper viral structural polypeptides in cells transformed by clonal isolates of woolly monkey sarcoma virus. J Virol (1975) 1.22
Microtubule detachment from the microtubule-organizing center as a key event in the complete turnover of microtubules in cells. Eur J Cell Biol (1990) 1.21
Polyadenylate in the virion RNA of mouse hepatitis virus. J Biochem (1977) 1.21
A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation. J Biol Chem (2000) 1.20
Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun (1999) 1.20
Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Intervent Radiol (1992) 1.20
Immunohistochemical localization of smooth muscle myosin in normal human tissues. J Histochem Cytochem (1985) 1.19
Purification and characterization of chicken liver T-protein, a component of the glycine cleavage system. J Biol Chem (1982) 1.18
Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes. Arch Virol (1981) 1.18
Adolescent exercise associated with long-term superior measures of bone geometry: a cross-sectional DXA and MRI study. Br J Sports Med (2009) 1.18
Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood (1994) 1.18
Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells. FEBS Lett (1997) 1.18
Small cell carcinoma of the endometrium: report of three cases and literature review. Int J Gynecol Cancer (2004) 1.18
Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res (1992) 1.17